Incyte Corp (INCY)
75.39
-0.36
(-0.48%)
USD |
NASDAQ |
Nov 05, 09:47
Incyte Total Assets (Quarterly): 5.012B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.012B |
| June 30, 2024 | 4.662B |
| March 31, 2024 | 7.136B |
| December 31, 2023 | 6.782B |
| September 30, 2023 | 6.388B |
| June 30, 2023 | 6.208B |
| March 31, 2023 | 5.798B |
| December 31, 2022 | 5.841B |
| September 30, 2022 | 5.510B |
| June 30, 2022 | 5.319B |
| March 31, 2022 | 5.054B |
| December 31, 2021 | 4.933B |
| September 30, 2021 | 4.199B |
| June 30, 2021 | 3.905B |
| March 31, 2021 | 3.661B |
| December 31, 2020 | 3.561B |
| September 30, 2020 | 3.307B |
| June 30, 2020 | 3.212B |
| March 31, 2020 | 2.752B |
| December 31, 2019 | 3.427B |
| September 30, 2019 | 3.215B |
| June 30, 2019 | 2.948B |
| March 31, 2019 | 2.754B |
| December 31, 2018 | 2.646B |
| September 30, 2018 | 2.520B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.397B |
| March 31, 2018 | 2.306B |
| December 31, 2017 | 2.303B |
| September 30, 2017 | 2.374B |
| June 30, 2017 | 1.639B |
| March 31, 2017 | 1.607B |
| December 31, 2016 | 1.639B |
| September 30, 2016 | 1.544B |
| June 30, 2016 | 1.418B |
| March 31, 2016 | 1.104B |
| December 31, 2015 | 1.007B |
| September 30, 2015 | 931.93M |
| June 30, 2015 | 930.34M |
| March 31, 2015 | 862.62M |
| December 31, 2014 | 796.48M |
| September 30, 2014 | 785.26M |
| June 30, 2014 | 679.11M |
| March 31, 2014 | 666.83M |
| December 31, 2013 | 629.57M |
| September 30, 2013 | 357.40M |
| June 30, 2013 | 334.22M |
| March 31, 2013 | 330.28M |
| December 31, 2012 | 330.42M |
| September 30, 2012 | 296.54M |
| June 30, 2012 | 311.97M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.752B
Minimum
Mar 2020
7.136B
Maximum
Mar 2024
4.833B
Average
4.973B
Median
Total Assets (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | 476.95M |
| Merck & Co Inc | 112.63B |
| Pfizer Inc | 216.19B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Allogene Therapeutics Inc | 646.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.841B |
| Shareholders Equity (Quarterly) | 3.171B |
| Current Ratio | 1.870 |